Multimillion-dollar grants to study mental health, maternal health and tobacco product regulation boosted The Ohio State University College of Medicine’s total research funding to $477.3 million during the 2024 fiscal year.
College of Medicine research funding is up 13% from $421.4 million in 2023. The National Institutes of Health, part of the U.S. Department of Health and Human Services, awarded the College of Medicine more than $245 million in grants, contracts and subcontracts. The remaining funding came from other government agencies, nonprofit foundations and industry contracts.
Carol R. Bradford, dean of the College of Medicine, credits part of the growth in funding to an increasing focus on collaboration across disciplines.
“The College of Medicine is part of one of the nation’s top academic medical centers, so we’re uniquely positioned for collaboration and team science,” Bradford said. “Our faculty, staff and learners are working to advance research that uncovers timely and much-needed solutions to evolving health care challenges.”
Ohio State’s fiscal year 2024 research portfolio has 108 new awards over $1 million, including:
- A $20 million grant from the Ohio Department of Mental Health and Addiction Services to fund the SOAR study, a multigenerational research initiative to identify the biological, psychological and social patterns associated with mental health conditions.
- A $20 million Tobacco Center of Regulatory Science grant from the Food and Drug Administration’s (FDA) Center for Tobacco Products and the National Institutes of Health to conduct research aimed at gathering scientific evidence needed to better inform the FDA’s regulation of tobacco products.
- A $14 million grant from the Patient-Centered Outcomes Research Institute to study whether a higher daily dose of aspirin is more effective in decreasing the risk of dangerous blood pressure complications among some pregnant people.
“We are pleased to continue working with our partners and stakeholders to expand our research efforts and amplify their impacts,” said Peter Mohler, executive vice president for Research, Innovation and Knowledge at Ohio State and chief scientific officer of The Ohio State University Wexner Medical Center.
There are more than 3,200 active research awards in fiscal year 2024.
The success of the College of Medicine mirrors that of the overall university: Ohio State’s annual research and development expenditures set a new university record of $1.449 billion in fiscal year 2023, a 6% increase over the previous fiscal year.